Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, rando... von Hurwitz, Barrie J., MB, MRCP, Jeffery, Douglas, MD, Arnason, Barry, MD, Bigley, Kim, MD, Coyle, Patricia, MD, Goodin, Douglas, MD, Kaba, Samer, MD, Kirzinger, Stephen, MD, Lynch, Sharon, MD, Mandler, Raul, MD, Mikol, Daniel, MD, Rammohan, Kottil, MD, Sater, Richard, MD, Sriram, Subramaniam, MD, Thrower, Ben, MD, Boateng, Francis, PhD, Jakobs, Peter, Dipl Math, Wash, Mary Beth, MD, Bogumil, Timon, MD

Volltext

Tolerability and Safety Profile of 12-to 28-Week Treatment with Interferon Beta-1b 250 and 500 μg QOD in Patients with Relapsing-Remitting Multiple Sclerosis : A Multicenter, Rando... von HURWITZ, Barrie J, JEFFERY, Douglas, MIKOL, Daniel, RAMMOHAN, Kottil, SATER, Richard, SRIRAM, Subramaniam, THROWER, Ben, BOATENG, Francis, JAKOBS, Peter, WASH, Mary Beth, BOGUMIL, Timon, ARNASON, Barry, BIGLEY, Kim, COYLE, Patricia, GOODIN, Douglas, KABA, Samer, KIRZINGER, Stephen, LYNCH, Sharon, MANDLER, Raul

Volltext

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, r... von Hurwitz, Barrie J, Jeffery, Douglas, Arnason, Barry, Bigley, Kim, Coyle, Patricia, Goodin, Douglas, Kaba, Samer, Kirzinger, Stephen, Lynch, Sharon, Mandler, Raul, Mikol, Daniel, Rammohan, Kottil, Sater, Richard, Sriram, Subramaniam, Thrower, Ben, Boateng, Francis, Jakobs, Peter, Wash, Mary Beth, Bogumil, Timon

Volltext